Chronic Lower Back Pain Market
Chronic Lower Back Pain Market - Global Industry Assessment & Forecast
Segments Covered
- By Drug Class Non-steroidal Anti-Inflammatory Drugs, Antidepressants, Analgesic, Opioids, Others
- By Route of Administration Oral, Topical, Others
- By Distribution Channel Hospital Pharmacies, Retail & Online Pharmacies
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2023 |
Forecast Years: | 2024 - 2032 |
Historical Years: | 2018 - 2022 |
Revenue 2023: | USD 2.5 Billion |
Revenue 2032: | USD 5.52 Billion |
Revenue CAGR (2024 - 2032): | 9.2% |
Fastest Growing Region (2024 - 2032) | Asia Pacific |
Largest Region (2023): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Chronic Lower Back Pain Market - Segment Analysis
- Overview
- Global Chronic Lower Back Pain Market, 2016 - 2028 (USD Million)
-
Global Chronic Lower Back Pain Market - by Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
-
Global Chronic Lower Back Pain Market - by Route of Administration
- By Oral
- By Topical
- By Others
-
Global Chronic Lower Back Pain Market - by Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
-
Global Chronic Lower Back Pain Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Chronic Lower Back Pain Market - Segment Analysis
- Overview
- North America Chronic Lower Back Pain Market, 2016 - 2028 (USD Million)
-
North America Chronic Lower Back Pain Market, by Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
-
North America Chronic Lower Back Pain Market, by Route of Administration
- By Oral
- By Topical
- By Others
-
North America Chronic Lower Back Pain Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
-
North America Chronic Lower Back Pain Market, by Country
- U.S.
- U.S. Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- U.S. Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- U.S. Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- U.S. Chronic Lower Back Pain Market, By Drug Class
- Canada
- Canada Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- Canada Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- Canada Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- Canada Chronic Lower Back Pain Market, By Drug Class
- Mexico
- Mexico Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- Mexico Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- Mexico Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- Mexico Chronic Lower Back Pain Market, By Drug Class
- U.S.
-
Europe Chronic Lower Back Pain Market - Segment Analysis
- Overview
- Europe Chronic Lower Back Pain Market, 2016 - 2028 (USD Million)
-
Europe Chronic Lower Back Pain Market, by Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
-
Europe Chronic Lower Back Pain Market, by Route of Administration
- By Oral
- By Topical
- By Others
-
Europe Chronic Lower Back Pain Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
-
Europe Chronic Lower Back Pain Market, by Country
- Germany
- Germany Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- Germany Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- Germany Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- Germany Chronic Lower Back Pain Market, By Drug Class
- UK
- UK Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- UK Market, By Route of Administration
- By Oral
- By Topical
- By Others
- UK Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- UK Market, By Drug Class
- France
- France Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- France Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- France Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- France Chronic Lower Back Pain Market, By Drug Class
- Spain
- Spain Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- Spain Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- Spain Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- Spain Chronic Lower Back Pain Market, By Drug Class
- Italy
- Italy Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- Italy Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- Italy Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- Italy Chronic Lower Back Pain Market, By Drug Class
- BENELUX
- BENELUX Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- BENELUX Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- BENELUX Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- BENELUX Chronic Lower Back Pain Market, By Drug Class
- Rest of Europe
- Rest Of Europe Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- Rest Of Europe Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- Rest Of Europe Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- Rest Of Europe Chronic Lower Back Pain Market, By Drug Class
- Germany
-
Asia Pacific Chronic Lower Back Pain Market - Segment Analysis
- Overview
- Asia Pacific Chronic Lower Back Pain Market, 2016 - 2028 (USD Million)
-
Asia Pacific Chronic Lower Back Pain Market, by Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
-
Asia Pacific Chronic Lower Back Pain Market, by Route of Administration
- By Oral
- By Topical
- By Others
-
Asia Pacific Chronic Lower Back Pain Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
-
Asia Pacific Chronic Lower Back Pain Market, by Country
- China
- China Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- China Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- China Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- China Chronic Lower Back Pain Market, By Drug Class
- Japan
- Japan Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- Japan Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- Japan Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- Japan Chronic Lower Back Pain Market, By Drug Class
- India
- India Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- India Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- India Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- India Chronic Lower Back Pain Market, By Drug Class
- South Korea
- South Korea Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- South Korea Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- South Korea Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- South Korea Chronic Lower Back Pain Market, By Drug Class
- South East Asia
- South East Asia Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- South East Asia Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- South East Asia Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- South East Asia Chronic Lower Back Pain Market, By Drug Class
- Rest of Asia Pacific
- Rest of Asia Pacific Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- Rest of Asia Pacific Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- Rest of Asia Pacific Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- Rest of Asia Pacific Chronic Lower Back Pain Market, By Drug Class
- China
-
Latin America Chronic Lower Back Pain Market - Segment Analysis
- Overview
- Latin America Chronic Lower Back Pain Market, 2016 - 2028 (USD Million)
-
Latin America Chronic Lower Back Pain Market, by Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
-
Latin America Chronic Lower Back Pain Market, by Route of Administration
- By Oral
- By Topical
- By Others
-
Latin America Chronic Lower Back Pain Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
-
Latin America Chronic Lower Back Pain Market, by Country
- Brazil
- Brazil Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- Brazil Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- Brazil Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- Brazil Chronic Lower Back Pain Market, By Drug Class
- Argentina
- Argentina Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- Argentina Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- Argentina Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- Argentina Chronic Lower Back Pain Market, By Drug Class
- Rest of Latin America
- Rest of Latin America Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- Rest of Latin America Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- Rest of Latin America Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- Rest of Latin America Chronic Lower Back Pain Market, By Drug Class
- Brazil
-
Middle East & Africa Chronic Lower Back Pain Market - Segment Analysis
- Overview
- Middle East & Africa Chronic Lower Back Pain Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Chronic Lower Back Pain Market, by Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
-
Middle East & Africa Chronic Lower Back Pain Market, by Route of Administration
- By Oral
- By Topical
- By Others
-
Middle East & Africa Chronic Lower Back Pain Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
-
Middle East & Africa Chronic Lower Back Pain Market, by Country
- GCC Countries
- GCC Countries Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- GCC Countries Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- GCC Countries Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- GCC Countries Chronic Lower Back Pain Market, By Drug Class
- South Africa
- South Africa Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- South Africa Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- South Africa Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- South Africa Chronic Lower Back Pain Market, By Drug Class
- Rest of Middle East & Africa
- Rest of Middle East & Africa Chronic Lower Back Pain Market, By Drug Class
- By Non-steroidal Anti-Inflammatory Drugs
- By Antidepressants
- By Analgesic
- By Opioids
- By Others
- Rest of Middle East & Africa Chronic Lower Back Pain Market, By Route of Administration
- By Oral
- By Topical
- By Others
- Rest of Middle East & Africa Chronic Lower Back Pain Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail & Online Pharmacies
- Rest of Middle East & Africa Chronic Lower Back Pain Market, By Drug Class
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Johnson & Johnson Private Limited
- Medtronic
- Endo Pharmaceuticals Inc.
- Sanofi
- Merck & Co Inc.
- Koninklijke Philips N.V.
- Vertebral Technologies Inc.
- Boston Scientific Corporation
- Dr. Reddy’s Laboratories Ltd.
- Astellas Pharma Inc.
- SpineThera Inc.
- Pfizer Inc
- Teva Pharmaceutical Industries Ltd.
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Chronic Lower Back Pain in terms of revenue?
-
The global Chronic Lower Back Pain valued at USD 2.5 Billion in 2023 and is expected to reach USD 5.52 Billion in 2032 growing at a CAGR of 9.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Johnson & Johnson Private Limited, Medtronic, Endo Pharmaceuticals Inc., Sanofi, Merck & Co Inc., Koninklijke Philips N.V., Vertebral Technologies, Inc., Boston Scientific Corporation, Dr. Reddy’s Laboratories Ltd., Astellas Pharma Inc., SpineThera Inc., Pfizer Inc, Teva Pharmaceutical Industries Ltd..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 9.2% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Chronic Lower Back Pain include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Chronic Lower Back Pain in 2023.